Could a lower dose be better? new study tailors antipsychotic reduction to patient type
NCT ID NCT07152184
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study looks at whether people with schizophrenia who are stable on medication can safely lower their dose and still function well in daily life. Researchers will group 288 adults by their specific psychosis type and randomly assign them to either reduce or maintain their current antipsychotic dose. The goal is to see if a personalized dose-reduction strategy leads to better social and personal functioning over two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.